Evidence map›Paper›PMID 32222911›Full record

ReviewInternational journal of clinical pharmacy2020

Providing pharmacy services during the coronavirus pandemic.

Shao Liu, Ping Luo, Mimi Tang, Qin Hu, Joseph P Polidoro, Shusen Sun, Zhicheng Gong

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of clinical pharmacy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 234 citations in OpenAlex.

  1. Community pharmacy resiliency during Covid-19 pandemic in Iran: A qualitative study.Exploratory research in clinical and social pharmacy · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shao Liu *Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Ping Luo *Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Mimi TangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Qin HuDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Joseph P PolidoroDepartment of Pharmacy Practice, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA, 01119, USA.
Shusen SunDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. ssun@wne.edu.
Zhicheng GongDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China. gongzhicheng@csu.edu.cn.
Xiangya Hospital Central South University · CNHunan Academy of Traditional Chinese Medicine · CNWestern New England University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 19 (COVID-19) is quickly spreading across China and globally. Pharmacy services are an important pillar in public health to prevent and contain the COVID-19 pandemic. Chinese pharmacists have acted swiftly in the public health response in China, such as drafting professional service guidance to pharmacists and pharmacies, establishing emergency drug formularies, monitoring and resolving drug shortages, establishing remote pharmacy services to prevent human-to-human infections, providing event-driven pharmaceutical care, educating the public on infection prevention and disease management, and participating in clinical trials and drug evaluation. This commentary reviews the unique needs of pharmacy services in the COVID-19 pandemic, and shares our experiences with the international pharmacy community in the response to these needs.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralCommunity Pharmacy ServicesCOVID-19COVID-19 Drug TreatmentHumansPractice Guidelines as TopicSARS-CoV-2ChinaCoronavirusCOVID-19Pharmaceutical carePharmacistsPharmacy servicePublic health

Identifiers

PMID32222911
PMCPMC7101875
OpenAlexW3013519637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.